Lifshitz & Miller Law Firm Announces Investigation of Adeptus Health Inc., Avid Technology, Inc., Cempra, Inc., Clovis Oncology, Inc., Impax Laboratories, Inc., Ligand Pharmaceuticals Incorporated, Pattern Energy Group Inc. and Kandi Technologies Group, Inc.

NEW YORK, Dec.1, 2016 /PRNewswire/ --

Adeptus Health Inc. (ADPT)

Lifshitz & Miller announces investigation on behalf of ADPT investors concerning whether ADPT adequately disclosed its billing practices, especially with lower acuity level patients.

If you are an ADPT investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Avid Technology, Inc. (AVID)

Lifshitz & Miller announces investigation on behalf of AVID investors concerning whether AVID adequately disclosed the launch of its new NEXIS solution product offerings and third quarter 2016 bookings and revenues.

If you are an AVID investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Cempra, Inc. (CEMP)

Lifshitz & Miller announces investigation on behalf of CEMP investors concerning whether CEMP adequately disclosed the safety risks of CEMP's drug solithromycin for hepatotoxicity.

If you are a CEMP investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Clovis Oncology, Inc. (CLVS)

Lifshitz & Miller announces investigation on behalf of CLVS investors concerning whether CLVS adequately disclosed test data for rociletinib, CLVS' lung cancer drug.

If you are a CLVS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Impax Laboratories, Inc. (IPXL)

Lifshitz & Miller announces investigation on behalf of IPXL investors concerning whether IPXL engaged in a scheme to fix generic drug prices with other pharmaceutical companies.

If you are a IPXL investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Ligand Pharmaceuticals Incorporated (LGND)

Lifshitz & Miller announces investigation on behalf of LGND investors concerning whether LGND adequately disclosed certain deferred tax assets and outstanding convertible senior unsecured notes.

If you are an LGND investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Pattern Energy Group Inc. (PEGI)

Lifshitz & Miller announces investigation on behalf of PEGI investors concerning whether PEGI adequately disclosed various transaction, process level and monitoring controls.

If you are a PEGI investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Kandi Technologies Group, Inc. (KNDI)

Lifshitz & Miller announces investigation on behalf of KNDI investors. The investigation concerns whether KNDI violated federal securities laws by issuing false and misleading statements concerning KNDI’s financial results for the third quarter 2016.

If you are a KNDI investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

ATTORNEY ADVERTISING. © 2016 Lifshitz & Miller. The law firm responsible for this advertisement is Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz & Miller
Phone: 516-493-9780 
Facsimile: 516-280-7376
Email: [email protected]

SOURCE Lifshitz & Miller Law Firm

Related Links

http://jlclasslaw.com